港股收評：港股止步3連跌，恒指升0.78%重回萬九關口，醫藥、消費類股活躍
港股三大指數午後一度跳水轉跌，尾盤再度拉昇收升，恒指升0.78%重回萬九點上方，國指升0.8%，恒生科技指數升1%。
盤面上，權重科技股普遍上升帶動大市上揚；教育股普遍走高，細價股澳洲成峯高教大升25%領銜，藥品類股繼續活躍，生物科技股、醫美概念股方面領升，金斯瑞生物科技放量升超12%；餐飲股、體育用品股、啤酒股等消費股現普升行情，電信股、內險股、中字頭股等權重多數上升。另一方面，家電股、電力股、汽車經銷商股全天表現疲弱，半導體股、軍工股部分走低，龍頭中芯國際跌1.25%。南下資金全日大幅淨流入17.56億港元，大市成交額為766億港元。
具體來看：
科技股普遍上升，快手升超4%，小米、阿里巴巴升2%，京東、美團、網易均有升幅。
生物技術股領升大市，金斯瑞生物科技升近10%，康諾亞升近5%，榮昌生物升近4%，藥明生物、百濟神州等跟升。
餐飲股升幅靠前，海倫司升超3%，海底撈、百盛中國升超1%。
保險股普升，中國財險、友邦保險升超1%，中國人民保險、中國平安、中國人壽跟升。
電信股走強，中國聯通升近2%，中國電信、中國移動升超1%。
汽車股升跌不一，小鵬汽車、零跑汽車升超1%，理想汽車、長城汽車、比亞迪股份小幅跟升，吉利跌近1%，蔚來微跌。
內房股多數走低，碧桂園跌超5%，龍湖集團跌超1%，中國海外發展跌近1%，萬科企業、華潤置地微跌。
今日，南下資金淨流入17.54億港元，其中港股通（滬）淨流入11.22億港元，港股通（深）淨流入6.32億港元。
展望後市，中泰國際指出，對下半年港股不悲觀，中國經濟在全球基欽(庫存)週期、政策效應發力及服務業的支撐下，有望於2023年三季度逐漸進入被動去庫存週期。流動性方面，美國10年期債息將因政策利率見頂、美國經濟增長放緩及通脹逐漸下行而走出一波下行態勢，緩和對港股的估值及流動性的擠壓。港股的盈利預測已反映中國經濟經濟温和復甦，未來存在重新上修的機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
